ATTOGRAM CORP. – Trademark Portfolio

Entity Type: 03

ATTOGRAM CORP. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 5 Nice Classification classes. The owner is based in Bolton, Ontario L7E 1G4.

7-13 Holland Dr.

Bolton, Ontario L7E 1G4 , CA

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ATTOGRAM CORP.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

29
Meats & Processed Foods (1 filing)

Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does ATTOGRAM CORP. have?

ATTOGRAM CORP. has 8 U.S. trademarks filed with the USPTO.

What trademark classes does ATTOGRAM CORP. file in?

ATTOGRAM CORP. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment), Class 29 (Meats & Processed Foods), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is ATTOGRAM CORP.'s trademark registration success rate?

ATTOGRAM CORP. has a 0% trademark registration rate, with 0 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.